Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?
Jasper Therapeutics Ownership Summary
Jasper Therapeutics is owned by 68.35% institutional investors, and 31.65% retail investors. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.
JSPR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Jasper Therapeutics | 68.35% | - | 31.65% |
Sector | Healthcare Stocks | 45.73% | 8.14% | 46.12% |
Industry | Biotech Stocks | 43.86% | 7.98% | 48.16% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 39 | -7.14% | 74,996,253 | -18.08% | 68 | 0.97% | 17 | - | 9 | 28.57% |
Sep 30, 2023 | 42 | -14.29% | 91,546,602 | 3.92% | 83 | 0.84% | 17 | -10.53% | 7 | -30.00% |
Jun 30, 2023 | 49 | -3.92% | 88,090,697 | -5.98% | 99 | 0.88% | 19 | -57.78% | 10 | 900.00% |
Mar 31, 2023 | 51 | 121.74% | 93,692,255 | 362.76% | 106 | 20.15% | 45 | 350.00% | 1 | -83.33% |
Dec 31, 2022 | 23 | 21.05% | 20,246,590 | -0.44% | 22 | 4.32% | 10 | 11.11% | 6 | 200.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Polar Capital Healthcare Opports Inc | 581.54K | 3.85% | - |
Vanguard Total Stock Mkt Idx Inv | 401.22K | 2.67% | - |
Franklin Biotechnology Discv A(acc)USD | 367.37K | 2.45% | - |
iShares Russell 2000 ETF | 296.68K | 1.96% | -672.00 |
HBM Healthcare Investments AG Ord | 250.00K | 1.66% | - |
Franklin Biotechnology Discovery A | 212.24K | 1.41% | -24.60K |
Vanguard Institutional Extnd Mkt Idx Tr | 188.66K | 1.26% | - |
DWS ESG Biotech LC | 125.00K | 0.83% | 45.00K |
Fidelity Small Cap Index | 115.36K | 0.76% | -3.43K |
iShares Russell 2000 Growth ETF | 100.34K | 0.66% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Sell | $19.10K |
Jun 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Sell | $21.74K |
Mar 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Sell | $23.79K |
Feb 08, 2024 | Carlyle Group Inc. | Former 10% Owner | Buy | $2.46M |
Feb 08, 2024 | Velan Capital Investment Management LP | - | Buy | $4.53M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | 1 |
2024 Q2 | - | 1 |
2024 Q1 | 2 | 1 |
2023 Q4 | 5 | 1 |
2023 Q3 | - | - |
JSPR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools